Group Members

Shenzhen Borui Pharmaceutical Technology Co., Ltd. is a key subsidiary of BOJIMED Group, receiving full support and dedicated development. It provides comprehensive, one-stop services for the research and development of innovative drugs and novel therapies.

Guangzhou Jiutai Medical Device Technology Co., Ltd. is a CRO specializing in third-party outsourcing services for medical devices. Leveraging its parent company BOJIMED's (300404) over two decades of experience in the clinical trial industry, Jiutai Medical Device has accumulated extensive practical expertise in conducting clinical trials for Class III high-risk medical devices, particularly innovative medical devices. While actively expanding its market presence, the company vigorously enhances its technical capabilities and brand image, striving to establish a professional, rigorous, and responsible industry reputation in the field of medical device clinical trials. It aims to contribute its modest strength to the advancement of the medical device sector.

Humphrey Pharmaceutical Consulting LLC is a specialized consulting firm providing premium regulatory services to the pharmaceutical industry. From its founding in Maryland, USA in 2003 to its establishment in Nanjing, China in 2012, Humphrey has progressively built a service system centered on pharmaceutical regulations, with pillars encompassing drug registration, product development and compliance, commercial development, and project management.

Shanghai Famas Pharmaceutical Biotechnology Co., Ltd., abbreviated as “Famas Pharmaceutical,” is located in Shanghai Zhangjiang Pharmaceutical Valley. As a wholly domestic-funded, independent legal entity, it is a specialized Site Management Organization (SMO) dedicated to assisting clinical trial institutions with on-site management, clinical trials, and operational execution.

Boji Medical Technology (Beijing) Co., Ltd., a wholly-owned subsidiary of BOJIMED (Stock Code: 300404), is a full-service CRO company offering integrated solutions including IND/NDA regulatory consulting and communication, early-phase and large-scale clinical trials, clinical pharmacology and bioequivalence studies, as well as quantitative pharmacology and modeling and simulation services.

Suzhou Xuhui Testing Co., Ltd. was established in September 2016. It is recognized as a Jiangsu Provincial High-Tech Enterprise, a Jiangsu Provincial Private Technology Enterprise, and a Technology-Based SME. Located within the Kunshan Small Nucleic Acid Biomedical Industrial Park, the company occupies over 3,400 square meters of facilities and has established a comprehensive laboratory management system compliant with GLP regulations and the Laboratory Management Guidelines for Clinical Trial Bio-sample Analysis.